Funny Peculiar
01 July 2019
Funny Peculiar
UPDATE:
Thank you so much to Peculiar Productions for putting on such incredible shows in their rendition of Terry Pratchett’s classic comedy “Men At Arms”. We have been told that roughly 900 tickets were sold in total between the 21st-24th of August and we couldn't be more thankful as all proceeds are being donated towards our vital cause!
Thanks again and we are so glad to see that your show received such great reviews Find out more here
![](/images/common/Peculiar-1Page-Preview-800-x-500-px.png)
![](/images/common/Peculiar-1Mobile-600-x-800-px.png)
![](/images/common/Peculiar-1Desktop-1600-x-900-px.png)
![](/images/common/peculiar-2Desktop-1600-x-900-px.png)
![](/images/common/peculiar-2Page-Preview-800-x-500-px.png)
![](/images/common/peculiar-2Mobile-600-x-800-px.png)
Peculiar Productions is an amateur theatre company which puts on very accomplished productions, principally of Terry Pratchett adaptations. This year’s show brings to life on stage Terry Pratchett’s classic comedy-fantasy thriller, Men at Arms. The company gives all the proceeds from their shows to charity, and this year has chosen Nerve Tumours UK as the beneficiary.
The director, Matthew Hitchman, explains the connection to the charity.
“We chose Nerve Tumours UK as this year’s charity because one of our members, Sarah Burrows, sadly lost a good friend this year, who passed away due to the condition. As a company, we aim to give our audiences a great time, and also make a contribution to a worthwhile cause, so we’re delighted to be able to support the important work of Nerve Tumours UK. We’ll also take the opportunity at the shows to raise awareness about nerve tumours, a condition I suspect people know very little about – I certainly didn’t.”
![](/images/common/Mens-rehearsal-1Artboard-1.png)
![](/images/common/Mens-rehhearsal-2Artboard-1.png)
Filter News
![](https://nervetumours.org.uk/images/made/images/common/robina-weermeijer-3KGF9R_0oHs-unsplash_370x280_800_600_s_c1.jpg)
NF1 stem cell research study
Julieta is carrying out stem cell research to understand brain development in those with NF1
Read More![](https://nervetumours.org.uk/images/made/images/common/FB_IMG_1646043328094_370x280_800_600_s_c1.jpg)
Ava-Lily’s NF1 story
Ava-Lily is thriving at school despite various NF1 related difficulties - read her story
Read More![](https://nervetumours.org.uk/images/made/images/common/image_(12)_370x280_800_600_s_c1.jpg)
Westminster Virtual Rare Disease Day 2022 Reception
NTUK joined the annual international event aimed at raising awareness & highlighting the needs of people with rare diseases
Read More![](https://nervetumours.org.uk/images/made/images/common/NTUK_supports_RDD_370x280_800_600_s_c1.jpg)
Rare Disease Day 2022
Nerve Tumours UK joins events showcasing Rare Disease Day, hosted by the Genetic Alliance, on 28 February 2022
Read More![](https://nervetumours.org.uk/images/made/images/common/IMG_7612_370x280_800_600_s_c1.jpg)
Runderpants Winchester 2022
The Runderpants fun run makes a successful return to Winchester
Read More![](https://nervetumours.org.uk/images/made/images/common/fruit_fly_370x280_800_600_s_c1.jpg)
NF1 Research study with fly model
How can studying the brain of a fruit fly help with understanding of NF1?
Read More![](https://nervetumours.org.uk/images/made/images/common/2021-10-27_15-11-36_324_370x280_800_600_s_c1.jpg)
Stuart’s Schwannoma Story Part Two
Stuart's update takes us through the operation to remove the Schwannoma, recovery and getting back to marathon training.
Read More![](https://nervetumours.org.uk/images/made/images/common/IMG_4619_370x280_800_600_s_c1.jpg)
Sian & Connor’s story
Sian & Connor describe the invaluable support from NTUK during her pregnancy with baby Reuben
Read More![](https://nervetumours.org.uk/images/made/images/common/17397DC99F38479194C0E2ADD6B8CDA8_370x280_800_600_s_c1.jpg)
Anita, aka Fat Lady Slim, is running the London Marathon for NTUK
Anita is fundraising on behalf of niece Sophie & great-niece Lexie who have NF2 by running the London Marathon
Read More